Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation

Experimental Neurology

Volumn 146, Issue 2, 1997, Pages 305-314

  Misiewicz, Barbara ^a,d   Poltorak, Maciej ^b   Raybourne, Richard B ^c   Gomez, Maria ^a   Listwak, Samuel ^a   Sternberg, Esther M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN GRAFT; CONTROLLED STUDY; EMBRYO; FEMALE; HELPER CELL; HYPOTHALAMUS; INFLAMMATION; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031214741     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6446     Document Type: Article

References (42)

1. 1. Assenmacher, I., A. Szafarczuk, G. Alonso, G. Ixart, and G. Barbanel. 1987. Physiology of Neural Pathways Affecting CRH Secretion. Ann. N.Y. Acad. Sci. 512: 149-161.
2. 2. Berkenbosch, F. J., A. Voers, F. Drey, F. Tilders, and H. Besedovsky. 1987. Corticotropin releasing factor-producing neurons in the rat activated by interleukin-1. Science 238: 524-526.
3. 3. Bernton, E. W., J. W. Beach, R. C. Holaday, and H. G. Smallridge. 1987. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238: 519-521.
4. 4. Breder, C. D., C. A. Dinarello, and C. B. Saper. 1988. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240: 321-324.
5. 1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat. J. Neurochem. 59: 1062-1069.
6. 6. Derijk, R., and E. M. Sternberg. 1994. Corticosteroid action and neuroendocrine-immune interactions. Ann. N.Y. Acad. Sci. 746: 33-41.
7. 7. Fontana, A., E. Weber, and J. M. Dayer. 1984. Synthesis of interleukin-1/endogenous pyrogen in the brain of endotoxin treated mice. J. Immunol. 133: 1696-1698.
8. 8. Fowell, D., A. J. McKnight, F. Powrie, R. Dyke, and D. Mason. 1991. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123: 37-64.
9. 9. Giulian, D., T. J. Baker, L-C. N. Shih, and L. B. Lachman. 1986. Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164: 594-604.
10. 10. Goldstein, D. S., M. Garty, G. Bagdy, K. Szemeredi, E. M. Sternberg, S. Listwak, K. Pacak, A. Deka-Starosta, A. Hoffman, P. C. Chang, R. Stull, P. W. Gold, and I. J. Kopin. 1993. Role of CRH in glucopenia-induced adrenomedullary activation in rats. J. Neuroendocrinol. 5: 475-486.
11. 11. Green, P. G., J. Luo, P. Heller, and J. D. Levine. 1993. Modulation of bradykinin-induced plasma extravasation in the rat knee joint sympathetic co-transmitters. Neuroscience 52: 451-458.
12. 12. Irwin, M., R. L. Hauger, M. Brown, and K. T. Britton. 1998. CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am. J. Physiol. 255: R744-R747.
13. 13. Jordan, F. L., and W. E. Thomas. 1988. Brain macrophages: questions of origin and interrelationship. Brain. Res. Rev. 13: 165-178.
14. 14. Livnat, S., S. Y. Felten, S. L. Carlson, D. Lorton Bellinger, and D. L. Felten. 1985. Involvement of Peripheral and Central Catecholamine Systems in Neural-Immune Interactions. J. Neuroimmunol. 10: 5-30.
15. 15. Love, A., J. I. Rader, L. J. Crofford, R. B. Raybourne, M. A. Principato, S. W. Page, M. W. Trucksess, M. J. Smith, E. M. Dugan, M. L. Turner, E. Zelazowski, P. Zelazowski, and E. M. Sternberg. 1993. Pathological and immunological effects of ingesting L-tryptophan and 1,1′-ethylidenebis (L-tryptophan) in Lewis rats. J. Clin. Invest. 91: 804-811.
16. 16. Madden, K. S., J. A. Moynihan, G. J. Brenner, S. Y. Felten, D. L. Felten, and S. Livnat. 1994. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunol. 49: 77-87.
17. 17. Mason, D., I. Macphee, and F. Antoni. 1990. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70: 1-5.
18. 18. Michelson, D., B. Misiewicz-Poltorak, R. B. Raybourne, P. W. Gold, and E. M. Sternberg. 1994. Imipramine reduces the local inflammatory response to carrageenan. Agents Actions 42: 25-28.
19. 19. Misiewicz, B., E. Zelazowska, R. B. Raybourne, G. Cizza, P. W. Gold, and E. M. Sternberg. Inflammatory responses to carrageenan injection in LEW/N and F344/N rats: LEW/N rats show sex and age dependent changes in inflammatory reactions. Neuroimmunomodulation, in press.
20. 20. Misiewicz, B., M. Poltorak, M. Gomez, J. R. Glowa, P. W. Gold, and E. M. Sternberg. 1996. Intracerebroventricularly transplanted embryonic neural tissue from inflammatory-resistant F344/N rats decreases acoustic startle responses in inflammatory-susceptible LEW/N rats. Cell Transplant 5: 287-291.
21. 21. Misiewicz-Poltorak, B., E. Zelazowska, M. Gomez, P. W. Gold, and E. M. Sternberg. 1993. Intra-cerebroventricular transplantation of F344/N rats embryonic hypothalamic tissue is associated with reduction of peripheral inflammatory responses in inflammatory disease susceptible LEW/N rats. Soc. Neurosci. Abstr. 19: 763.
22. 22. Munck, A., and P. M. Guyre. 1989. Glucocorticoid physiology and homeostasis in relation to anti-inflammatory actions. In Anti-inflammatory Steroid Action: Basic and Clinical Aspects (R. P. Schleimer, H. N. Claman, and A. Oronsky, Eds.), pp. 30-47. Academic Press, San Diego.
23. 23. Papp, I., K. J. Wieder, T. Sablinski, P. J. O'Connell, E. L. Milford, T. B. Strom, and J. W. Kupiec-Weglinski. 1992. Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipents of cardiac allografts. J. Immunol. 148: 1308-1314.
24. 24. Poltorak, M., and W. J. Freed. 1990. BN rats do not reject F344 brain allografts even after systemic sensitization. Ann. Neurol. 29: 377-387.
25. 25. Poltorak, M., and W. J. Freed. Transplantation into the CNS in Immunology of the Nervous System (R. W. Keane and W. F. Hickey, Eds.), Oxford University Press, in press.
26. +T cells In Vitro. J. Immunol. 156: 2406-2412.
27. 27. Rinner, I., and K. Schauenstein. 1991. The parasympathetic nervous system takes part in the immuno-neuroendocrine dialogue. J. Neuroimmunol. 34: 165-172.
28. 28. Sapolsky, R. C., G. Rivier, P. Yamamoto, P. Plotsky, and W. Vale. 1987. Interleukin-1 stimulates the secretion of hypothalamic corticotropin releasing factor. Science 238: 522-524.
29. 29. Seyle, H. 1953. On the mechanism through which hydrocortisone affects the resistance of tissue to injury. J. Am. Med. Assoc. 152: 1207-1213.
30. 30. Smith, C. C., E. Haser, N. K. Renaud, A. Leff, S. Aksentijevich, G. P. Chrousos, R. L. Wilder, P. W. Gold, and E. M. Sternberg. 1992. Increased hypothalamic [3H]flunitrazepam binding in hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats. Brain. Res. 569: 295-299.
31. 31. Smith, C. C., G. Cizza, M. Gomez, C. Greibler, P. W. Gold, and E. M. Sternberg. 1994. The estrous cycle and pituitary-ovarian function in Lewis and Fischer rats. Neuroimmunomodulation 1: 231-235.
32. 32. Sternberg, E. M., M. Hill, G. P. Chrousos, T. Kamiliaris, S. J. Listwak, P. W. Gold, and R. L. Wilder. 1989. Inflammatory mediators-induce hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA 86: 2374-2378.
33. 33. Sternberg, E. M., W. S. Young, R. Bernardini, A. E. Calogero, G. P. Chrousos, P. W. Gold, and R. L. Wilder. 1989. A central nervous system defect in biosyntesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA 86: 4471-1475.
34. 34. Sternberg, E. M., G. P. Chrousos, R. L. Wilder, and P. W. Gold. 1992. The stress response and the regulation of inflammatory disease. Ann. Intern. Med. 117: 854-66.
35. 35. Sternberg, E. M., C. C. Smith, R. J. Omeljaniuk, H. J. Witfield Jr., S. Aksentijevich, M. Fellows, E. Zelazowski, and P. W. Gold. 1994. Differential type 1 (mineralocorticoid) and type 2 (glucocorticoid) receptor expression in Lewis and Fischer rats. Neuroimmunomodulation 1: 66-73.
36. 36. Sundar, S. K., M. A. Cierpal, C. Kilts, J. C. Ritchie, and J. M. Weiss. 1990. Brain IL-1-induced immunosupression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J. Neurosci. 10: 3701-3706.
37. 37. Whitfield, H. J., L. S. Brady, M. A. Smith, R. J. Mamalaki, and M. Herkenham. 1990. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell Mol. Neurobiol. 10: 45-157.
38. 38. Whitnall, M. H., R. S. Perlstein, E. H. Mougey, and R. Neta. 1992. Effect on interleukin-1 on the stress-responsive and -nonresponsive subtype of corticotropin-releasing hormone neurosecretory axons. Endocrinology 131: 37-44.
39. 39. Wick, G., S. Hu, and G. Kroemer. 1993. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrine Rev. 14: 539-563.
40. 40. Widner, H., and P. Brundin. 1988. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res. 13: 287-324.
41. 41. Woloski, B. M., E. M. Smith, W. J. Meyer, G. M. Fuller, and J. E. Blalock. 1985. Corticotropin-releasing activity of monokines. Science 230: 1035-1037.
42. 42. Zelazowski, P., V. P. Patchev, E. B. Zelazowska, G. P. Chrousos, P. W. Gold, and E. M. Sternberg. 1993. Release of hypothalamus corticotropin-releasing hormone and arginine-vasopressin by interleukin 1b and aMSH: studies in rats with different susceptibility to inflammatory disease. Brain Res. 58: 106-110.